A 12-ounce beer at 5% ABV, a 5-ounce glass of wine at 12% ABV, and a 1.5-ounce shot of 80-proof spirits each deliver 0.6 ounces of pure ethanol
Research Applications 99% purity
BPC-157 Capsule Side Effects: Oral User Guide BPC-157 capsule side effects: nausea in 20-30% of users, diarrhea days 1-5, fewer headaches than injectable
Consumer-facing claims about BPC-157 efficacy in humans for tendinopathy, joint pain, gastrointestinal disorders, or neurological conditions therefore extrapolate from rat and HUVEC work and are not supported by controlled human evidence
Given this wide-ranging protective role, low levels of glutathione have been shown to be incompatible with optimum health
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)